Gå til innholdet


PHARMAQ`s technology ensures high quality research & development enabling us to stay in the forefront with new products and solutions to our global aquaculture customers.

We operate in a dynamic market that requires advanced technical solutions to be developed in shortest possible time.

Our research and development laboratory facilities are fully equipped for contained work on all aspects of vaccine development. 

All our fish vaccines are manufactured in a state of the art facility in Overhalla, Norway. Manufacturing of twenty five different fish vaccines involves complex operating procedures as well as logistic challenges. In taking vaccines from the laboratory scale to a commercial production level we believe the long term experience and competencies of our employees add strength to our flexibility and global business.   

We also aim to be in forefront within new technologies. As an example we have developed a micro dose vaccine concept that enables the fish farmer to reduce the injection dose to the micro level of 0.05 millilitre per fish. This improves both the side effect profile and growth of the fish. Our customers can benefit from our eagerness to constantly seek new innovative solutions.

> Learn more about our value chain


Samples from diseased fish of a variety of species of different geographical origin are sent directly to our dedicated team of bacteriologists and virologists in R&D for cultivation and characterization. At this stage, the key to success is the joint efforts of our PHARMAQ field force in different regions of the world and cooperation with our external partners including various scientific institutes, fish farmers and fish health personnel.

Cultivation and characterization of virus and bacteria challenge our R&D people. In some cases it even results in identification of previous uncharacterized pathogens.

PHARMAQ actively utilizes IPR actively to secure freedom to operate and to create value and competitive advantages. Several patents and patent applications covering future products and technologies are held by the company.

Research & Development

Identifying the best solutions to our customers' needs for new vaccines and fish health products, requires dedicated and targeted R&D efforts. Effective vaccine solutions to different bacterial and viral diseases depend upon extensive research and development and a broad range of competencies and highly equipped technical facilities.

The causative pathogen for a disease is usually already known before we start development of new vaccine component. Challenges lies in the ability to identify and characterize the best protective antigens, how to produce them and to optimize the way in which the antigens are presented to the fish in order to obtain protection against disease.

The rate of success of introducing new products and development of efficient processes is founded on the firm commitment to re-invest in R&D and related competencies in the PHARMAQ value chain.

Documentation and registration

Documentation requirements for new products are strictly regulated. Through all steps of research, development and product testing the interaction with the PHARMAQ regulatory department is essential in establishing high quality product documentation for different regulatory bodies around the world.

Our vaccines and therapeutics hold veterinary medicinal product licenses in each country in which they are sold. These licenses certify to the quality, safety, efficacy and environmental effects of each product in the local environment.


All PHARMAQ's vaccines are manufactured at our well recognized facility at Overhalla in Norway. Specific diseases in different farmed fish species and regions need separate vaccine and therapeutic solutions. Careful production planning and logistics combined with flexibility, new ideas and core competencies in vaccine manufacturing make this possible.

Quality is documented in every step from preparation of seed material to final product and throughout the product life cycle. Our quality system ensures that the defined product is manufactured and tested the same way every time, securing that the final product meets the requirements regarding quality, safety and efficacy. The final products are released by a Qualified Person (QP), approved by the authorities. As a pharmaceutical company we are frequently inspected by different national regulatory authorities in order to prove our standards.

Customer Service

By providing environmentally sound, safe and efficacious health products and services to our global aquaculture customers, we will continue to meet our main objective namely to be selected by our customers as their preferred supplier and partner. We put pride in being flexible and create customer satisfaction through high quality service and products.

We can only be successful in this effort if our customers produce predictable yields and healthy profits.

PHARMAQs Pharmacovigilance system is an integral part of post marketing activities in the field of veterinary medicinal products.

Did you know...

We allocate around 18% of our revenue to research and development to provide environmentally sound, safe and efficacious products for the aquaculture industry.